# Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

Source: https://onco.cc/key-papers/paper-porras-costa-rica-vaccine-trial-11-years-lancet-oncol-2020/  
OnCo record `paper-porras-costa-rica-vaccine-trial-11-years-lancet-oncol-2020` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

At the year 11 visit, none of 1,913 women given the bivalent HPV vaccine in Costa Rica had new HPV 16/18 precancer of the cervix, against 34 of 2,233 unvaccinated women.

## Summary

The Costa Rica Vaccine Trial, publicly funded and begun before the HPV vaccines were licensed, randomised women aged 18 to 25 between June 2004 and December 2005 to three doses of the bivalent HPV 16/18 vaccine or a hepatitis A control vaccine, followed them for 4 years, and then followed the vaccinated group for 7 more years against a new unvaccinated control group. The primary outcome was HPV 16/18-associated CIN2 or worse.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: Lancet Oncology
- Year: 2020
- DOI: 10.1016/S1470-2045(20)30524-6
- Authors: Porras C, Tsang SH, Herrero R, Guillén D, et al.
- Findings: 7,466 women were enrolled: 3,727 received the HPV vaccine and 3,739 the control vaccine.; At year 11, efficacy against incident HPV 16/18-associated CIN2+ was 100% (95% CI 89.2 to 100): 34 of 2,233 unvaccinated women and none of 1,913 vaccinated women had CIN2+.; Cumulative efficacy against HPV 16/18-associated CIN2+ over 11 years was 97.4% (95% CI 88.0 to 99.6).; No serious adverse events were judged related to the vaccine.
- What it means: Protection from the bivalent HPV vaccine against the precancers that lead to cervical cancer lasted more than a decade.
- Caveats: The control group was replaced after year 4, and the follow-up phase was open-label.

## Sources

- DOI: https://doi.org/10.1016/S1470-2045(20)30524-6
- PubMed: https://pubmed.ncbi.nlm.nih.gov/33271093/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- drugs: [HPV bivalent vaccine (types 16 and 18)](https://onco.cc/drugs/hpv-bivalent-vaccine/)
- institutions: [Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA (ACIB-FUNIN)](https://onco.cc/institutions/acib-funin-costa-rica/), [National Cancer Institute (NIH)](https://onco.cc/institutions/nci/)

---
JSON: https://onco.cc/api/v1/entities/paper-porras-costa-rica-vaccine-trial-11-years-lancet-oncol-2020.json